Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.57 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.57 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalimide SCHEMBL28729831 | 0.85 | EHMT2 (0.42) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL3647399 | 0.85 | NPC1 (0.61) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL2874801 | 0.85 | NPC1 (0.61) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| Hydrogen Sulfide SCHEMBL27801563 | 0.83 | NPC1 (0.59) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL13882921 | 0.82 | EHMT2 (0.53) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL9846637 | 0.79 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL11036195 | 0.79 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL10051085 | 0.78 | EHMT2 (0.48) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL11833495 | 0.78 | EHMT2 (0.70) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 | |
| SCHEMBL2618715 | 0.78 | EHMT2 (0.77) | EHMT2EHMT1APOBEC3GL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110256485-A | A kind of phosphatide cpd and preparation method thereof | 东南大学 | 2019-09-20 | — | — | CN | claimed |
| CN-110256485-A | A kind of phosphatide cpd and preparation method thereof | 东南大学 | 2019-09-20 | — | — | CN | disclosed |
| CN-110256485-A | A kind of phosphatide cpd and preparation method thereof | 东南大学 | 2019-09-20 | — | — | CN | disclosed |
| US-20100222546-A1 | METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-09-02 | — | — | US | disclosed |
| WO-2008066816-A2 | DERIVATIZATION OR LIGATON OF PEPTIDES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2008-06-05 | — | — | WO | disclosed |
| EP-1259524-A2 | NUCLEOTIDES AND POLYNUCLEOTIDES IMMOBILISED ON A SOLID SUPPORT VIA A DISULPHIDE LINKAGE | Amersham Biosciences UK Limited (GB) | 2002-11-27 | — | — | EP | disclosed |
| WO-2000053616-A2 | NUCLEOTIDES AND POLYNUCLEOTIDES IMMOBILISED ON A SOLID SUPPORT VIA A DISULPHIDE LINKAGE | AMERSHAM PHARMACIA BIOTECH UK LTD (GB) | 2000-09-14 | — | — | WO | disclosed |
| US-4053606-A | ANTIINFLAMMATORY AND ANTIARTHRITIC AGENTS | MERCK & CO., INC. (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222546-A1 | METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES | PTMS, STT3A, GCG | EHMT2 3464/4885EHMT1 3533/4885APOBEC3G 1056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.